The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
News Roundup from Rheumatology Network
August 30th 2019In this week's rheumatology news roundup, we feature a Q&A with Dr. Aryeh M. Abeles who talks with Rheumatology Network about his concerns with the black box warning label for the gout treatment febuxostat. We also include a story on addressing prescription abdandonment in rheumatoloyg. These and other stories in today's news roundup.
Introducing The Lancet Rheumatology
August 29th 2019This week, the British medical journal The Lancet, launched a new journal that focuses strictly on rheumatology. Aptly called "The Lancet Rheumatology," the journal's mission is to "provide an independent voice to the rheumatology community and to the millions of patients living with these conditions."
Black Box Blues for Gout Treatment Febuxostat
August 29th 2019Aryeh M. Abeles, M.D., talks with Rheumatology Network about the FDA's black box label for febuxostat, a gout treatment which, according to the results of one clinical trial, was shown to be associated with an increased risk of mortality. In this Q&A, Dr. Abeles, says the decision was based on flawed data.
Follow-ups may prevent prescription abandonment
August 27th 2019Nonadherence to a medication regimen is a problem in all of medicine, not just rheumatology. About 50 percent of all medications for chronic diseases are not taken as prescribed. Put another way, about two in every three Americans who have regular prescriptions aren’t taking them or aren’t taking them on schedule.
September is Rheumatic Disease Awareness Month
August 27th 2019September is more than back to school and the arrival of pumpkin-spice-flavored everything. It is also Rheumatic Disease Awareness Month, a national effort created by the American College of Rheumatology (ACR) in 2016 to bring attention to the more than 100 conditions that fall under the umbrella of rheumatic disease.
Early-Onset Gout May be Associated with Increased Cardiovascular Disease
August 27th 2019Patients diagnosed with gout at age 40 or younger may be at increased risk for cardiovascular disease and recurrent gout compared to those diagnosed later in life, according to a new study published in ACR Open Rheumatology.
The Negative Consequences of a Missed Diagnosis
August 26th 2019A missed diagnosis can have negative consequences for patients, making it critical for providers to have a better understanding of vasculitis and its related syndromes. In a presentation given at the Rheumatology Nurses Society annual meeting earlier this month, Jeffrey Kaine, M.D., an independent rheumatology consultant based in Cullowhee, N.C., discussed the challenges in diagnosing and treating vasculitis. In this Q&A, Dr. Kaine covers some of the high points from his talk.
PsA Quiz: Is there a link between gluten containing food products and arthritic flares?
August 26th 2019Can gluten-containing food products trigger a psoriatic arthritis flare? How well does the average psoriatic arthritis patient understand their condition? Learn more in today's psoriatic arthritis quiz.
New Ankylosing Spondylitis, Axial Spondyloarthritis Guidelines Released
August 23rd 2019A new set of guidelines has been released by the American College of Rheumatology, Spondylitis Association of America and the Spondyloarthritis Research and Treatment Network are offering guidance to physicians on treating axial spondyloarthritis.
Nearly 5% of Children on Biologics Develop Hypersensitivity Reactions, Study Shows
August 22nd 2019Children with active rheumatic disease exposed to multiple biological drugs should be monitored for hypersensitivity reactions, particularly during intravenous infusions, say researchers writing in Pediatric Allergy and Immunology this month
New JAK Inhibitor Approved for Rheumatoid Arthritis
August 19th 2019AbbVie announced on Friday that the Food and Drug Administration approved the oral once-daily JAK inhibitor Rinvoq (upadacitinib) for adults with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.
Rheumatology Network News Roundup
August 16th 2019In today's news roundup from Rheumatology Network, we highlight recent findings from ACR Open Rheumatology that examine infection risk in rheumatoid arthritis patients. Plus, we conduct a Q&A from a presentation made at the Rheumatology Nurses Society on alternative treatments for rheumatology conditions.
RA Treatments Work, but Raise Infection Risk
August 15th 2019Both TNF inhibitors and non-TNFi biologic DMARDs increase the risk of serious infection in rheumatoid arthritis patients compared to conventional synthetic DMARDs. Despite the risk, the treatments are effective in reducing disease activity, researchers report.
RNS Q&A: Medical Marijuana and CBD Oils
August 15th 2019One of the most common topics among healthcare providers and patients is the growing conversation around medical marijuana and CBD oils, particularly, it’s potential to alleviate pain and improve quality of life. In this Q&A, Nancy Delnay, a pediatric nurse practitioner with Akron Children’s Hospital, discussed the state of medical marijuana and CBD oils.